Teen mothers on three American Indian reservations improved on several measures of parenting after participating in Family Spirit, a home-visiting intervention developed with NIDA support. At 12 months postpartum, the women’s children exhibited reduced rates of emotional difficulties predicting later drug abuse and other behavioral problems. Infants at highest risk—those whose mothers had histories of drug abuse—benefited the most.
Presents research-based principles of adolescent substance use disorder treatment; covers treatment for a variety of drugs including, illicit and prescription drugs, alcohol, and tobacco; presents settings and evidence-based approaches unique to treating adolescents.
A meta-analysis of 13 genome-wide association studies of African Americans’ smoking patterns confirms the significance of genetic variation in region 15q25.1. The analysis also tentatively implicates several genome locations that have not previously been associated with smoking behaviors.
Addiction goes hand in hand with other mental illnesses. People with psychiatric conditions smoke at twice to four times the rate of the general population, and they are estimated to purchase nearly half of all cigarettes sold in this country. Yet physicians have tended to ignore the smoking behavior of their psychiatric patients.
Women who reached their majority in states with policies that restricted teens’ access to tobacco products were less likely to smoke from ages 18-34 than women in states without those policies. The research did not demonstrate that the policies had a comparable impact on men’s smoking.
Dr. Marilyn Huestis of NIDA’s Intramural Research Program talks about conducting research on drug effects with human subjects, developing tests to help law enforcement identify drugged drivers, and an assay to help identify children whose prenatal exposure to anti-HIV drugs may put them at risk for adverse developmental outcomes.
Menthol is a popular additive in cigarettes, potentially making them more palatable, but its use in these products is currently unregulated. The FDA has issued an Advance Notice of Proposed Rulemaking (ANPRM) to gather information and input from the public on whether that should change and, if so, how.